Open access · CC-BY
via OpenAlex
Mesenchymal stem cell therapy for liver disease: full of chances and challenges
Xue Feng Yang, Yan Meng, Zhipeng Han, Fei Ye, Lixin Wei, Chen Zong
Cell & Bioscience · 2020 · ▲ 110 citations
Abstract
Liver disease is a major health problem that endangers human health worldwide. Currently, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of liver transplantation. Mesenchymal stem cell therapy has been considered as a promising alternative approach for end-stage liver disease. Some clinical trials have confirmed the effectiveness of MSC therapy for liver disease, but its application has not been promoted and approved. There are still many issues that should be solved prior to using MSC therapy in clinical applications. The types of liver disease that are most suitable for MSC application should be determined, and the preparation and engraftment of MSCs should be standardized. These may be bottlenecks that limit the use of MSCs. We investigated 22 completed and several ongoing clinical trials to discuss these questions from a clinical perspective. We also discussed the important mechanisms by which MSCs play a therapeutic role in liver disease. Finally, we also proposed novel prospective approaches that can improve the therapeutic effect of MSCs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13578-020-00480-6
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Yang, X.F., Meng, Y., Han, Z., Ye, F., Wei, L., & Zong, C. (2020). Mesenchymal stem cell therapy for liver disease: full of chances and challenges. <em>Cell & Bioscience</em>. https://doi.org/10.1186/s13578-020-00480-6
Vancouver
Yang XF, Meng Y, Han Z, Ye F, Wei L, Zong C. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell & Bioscience. 2020. doi:10.1186/s13578-020-00480-6.
BibTeX
@article{xue2020Mesenc,
title = {Mesenchymal stem cell therapy for liver disease: full of chances and challenges},
author = {Xue Feng Yang and Yan Meng and Zhipeng Han and Fei Ye and Lixin Wei and Chen Zong},
journal = {Cell & Bioscience},
year = {2020},
doi = {10.1186/s13578-020-00480-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Pharmaceutical Design 2013
Open access · OA
Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy
Advances in Wound Care 2016
Preprint · OA
Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy
Stem Cells International 2019
Open access · CC-BY
Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
Pharmaceuticals 2023
Open access · CC-BY
Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
PubMed 2017
Preprint · OA
Mesenchymal Stem Cell Therapy for Ischemic Stroke.
Stem Cells Translational Medicine 2021
Open access · CC-BY